Breaking News
June 17, 2018 - Sunovion Announces FDA Acceptance of New Drug Application for Apomorphine Sublingual Film (APL-130277)
June 17, 2018 - Bid to beat obesity focuses on fat that keeps us warm
June 17, 2018 - Work Stress May Increase Risk of Developing Atrial Fibrillation
June 17, 2018 - New Zealand’s secret recipe for active school travel: The neighborhood built environment
June 17, 2018 - New Medscape report reveals sexual harassment rate of physicians
June 17, 2018 - Surgical Blood Transfusions Tied to Clot Risk
June 17, 2018 - CDC chief makes $375K, far exceeding his predecessors’ pay
June 17, 2018 - Education linked to higher risk of short-sightedness
June 17, 2018 - Patients with Moderate-to-Severe Ulcerative Colitis Achieved Clinical and Endoscopic Remission with Mirikizumab in Phase 2 Trial
June 17, 2018 - UA registers a more customised multifocal lens to correct presbyopia
June 17, 2018 - U.S. FDA and European Medicines Agency Accept Regulatory Submissions for Review of Talazoparib for Metastatic Breast Cancer Patients with an Inherited BRCA Mutation
June 17, 2018 - Vaginal estrogen tablets, moisturizers and placebo gel all can improve vaginal discomfort
June 17, 2018 - Addition of Bezafibrate Beneficial in Primary Biliary Cholangitis
June 17, 2018 - Radiation Therapy for Cancer – National Cancer Institute
June 17, 2018 - Technology could help pregnant women detect health complications
June 17, 2018 - Study finds drop in frequent use of ED after Affordable Care Act
June 17, 2018 - Do Antipsychotic Meds for Kids Raise Diabetes Risk?
June 17, 2018 - New light shed on mechanisms of paediatric epilepsy
June 17, 2018 - People who deeply grasp the pain or happiness of others also process music differently in the brain
June 16, 2018 - Scientists discover how cancer-targeting ‘Natural Killer’ cells are fueled in the body
June 16, 2018 - New England Journal of Medicine Publishes Pivotal Cemiplimab Trials Showing Positive Results in Advanced Cutaneous Squamous Cell Carcinoma
June 16, 2018 - Annual Report to the Nation: overall cancer mortality continues to decline, prostate cancer mortality has stabilized
June 16, 2018 - Ibuprofen, acetaminophen more effective than opioids in treating dental pain
June 16, 2018 - Intra-Cellular Therapies Initiates Rolling Submission of New Drug Application for Lumateperone for Treatment of Schizophrenia
June 16, 2018 - Price competition for generic drugs linked to increase in manufacturing-related recalls
June 16, 2018 - Researchers develop biomimetic nanosystem to deliver therapeutic proteins to target tumors
June 16, 2018 - Negative Pressure Wound Tx No Benefit for Lower Limb Open Fx
June 16, 2018 - Should I Get Screened for Prostate Cancer?
June 16, 2018 - Biochemist, physicist team to see antibacterial TCS deform mitochondria
June 16, 2018 - New 2D Superresolution mode for ZEISS Airyscan offers higher resolution in live cell imaging
June 16, 2018 - Money Spurs Those With Heart Disease to Step Lively
June 16, 2018 - Lower Dose of Prostate Cancer Drug with Food
June 16, 2018 - New findings demonstrate how the food we eat affects biochemical signals in the gut
June 16, 2018 - Scientists develop method to determine metabolic activity of neural networks
June 16, 2018 - Topical gel may lower breast cancer risk in women with dense breast tissue
June 16, 2018 - Research team diagnoses asthma with nasal brush test
June 16, 2018 - Dacomitinib Shows More than Seven-Month Improvement in Overall Survival Compared to an Established Therapy in Advanced NSCLC with EGFR-Activating Mutations
June 16, 2018 - Novel PET imaging noninvasively pinpoints colitis inflammation
June 16, 2018 - New clinical trial of MS drug will be first to recognize needs of wheelchair users
June 16, 2018 - Evoke Announces FDA Submission of New Drug Application for Gimoti
June 16, 2018 - New study links gray hair with immune system activity and viral infection
June 16, 2018 - Various E-cigarette flavorings may increase risk of cardiovascular disease
June 16, 2018 - Research sheds light on pathways involved in transmitting itch sensations from skin to brain
June 16, 2018 - Eminent biologist resigns over allegations of gender discrimination and sexual harassment
June 16, 2018 - Consuming sugary soft drinks can make you fat
June 16, 2018 - CDC: Preterm Births Increased in United States During 2014-2016
June 16, 2018 - Adolescents with hay fever have higher rates of anxiety and depression, lower resistance to stress
June 16, 2018 - Metabolic process providing energy to heart muscle fails to mature in babies with hypertrophy
June 16, 2018 - TU Graz researchers manipulate enzymes to build ring-shaped molecular structures
June 16, 2018 - Looking Good! Plastic Surgery for Men Surges
June 16, 2018 - Discovery of how HIV hedges its bets opens the door to new therapies
June 15, 2018 - Researchers evaluate left ventricular systolic function after pulmonary valve replacement
June 15, 2018 - New resource launched based on first-hand experiences of premature baby loss
June 15, 2018 - About Teen Pregnancy | Teen Pregnancy | Reproductive Health
June 15, 2018 - In southern Mozambique, one out of three people diagnosed with HIV do not disclose their status
June 15, 2018 - Researchers discover genomic characteristics that define testicular germ cell cancer
June 15, 2018 - Engineers create first 3D computer model to show breast duct development
June 15, 2018 - ANU scientists invent new system that could help crack down on illegal drug trade
June 15, 2018 - Study shows remarkable plasticity of the brain in finding work-arounds after catastrophic injuries
June 15, 2018 - Study finds higher response to anti-PD1 immunotherapy in older melanoma patients
June 15, 2018 - New Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Azacitidine Demonstrate Robust Responses and a Well Tolerated Safety Profile in Newly Diagnosed IDHm AML Patients
June 15, 2018 - Smoking, lack of exercise linked to early death after divorce
June 15, 2018 - Researchers identify gene enhancer that affects sex determination
June 15, 2018 - New collaboration integrates Intabio’s Blaze solution with Bruker’s mass spectrometers
June 15, 2018 - Blood samples can be used to uncover genetic secrets inside the brain
June 15, 2018 - Palatin Technologies Announces FDA Acceptance for Review of Bremelanotide NDA
June 15, 2018 - Can you rely on the drugs that your doctor prescribes?
June 15, 2018 - WHO: Paraguay achieves malaria-free status
June 15, 2018 - Investigating Enamel Nanostructure with Nanoindentation
June 15, 2018 - FDA Approves Moxidectin for the Treatment of River Blindness
June 15, 2018 - Researchers discover cell structure that plays a role in epigenetic inheritance
June 15, 2018 - Study shows how using service dogs may provide physiological benefits to veterans with PTSD
June 15, 2018 - New chemical solution could reduce chances of infection associated with root canal work
June 15, 2018 - Fat and carb rich foods preferred by the brain
June 15, 2018 - Scientists discover unique feature in the ‘antennae’ of light-sensing neurons
June 15, 2018 - Researchers observe increase in activity of neurons grown on single layer of graphene
June 15, 2018 - Researchers find enzyme responsible for aircraft noise-related vascular damage
June 15, 2018 - Study shows improvements in adherence, outcomes of gout patients receiving text message reminders
June 15, 2018 - Accelerated brain maturation linked to stress in childhood
June 15, 2018 - FDA Alert: Compounded Products Containing Triamcinolone-Moxifloxacin by Guardian Pharmacy Services (Dallas, Texas): Alert to Health Professionals
Hunting for immune cells’ cancer targets

Hunting for immune cells’ cancer targets

image_pdfDownload PDFimage_print
Proteins on immune cells called T-cell receptors (red) detect specific protein snippets (yellow) on the surface of other cells, including tumor cells. A new technique lets researchers find snippets linked to cancer. Credit: Eric Smith and Christopher Garcia

By screening millions of molecular targets, researchers have uncovered a tumor beacon detected by the immune cells of two patients with colorectal cancer.

The screening technology, developed by Howard Hughes Medical Institute Investigator (HHMI) Christopher Garcia and colleagues after almost 20 years of basic molecular studies of the immune system, may ultimately lead to more effective immunotherapies, which harness the body’s immune system to fight cancer. “This is going to widen the scope of our understanding for how tumors are recognized,” says Garcia, a protein engineer at the Stanford University School of Medicine.

More broadly, the method, reported online December 21, 2017, in the journal Cell, promises to illuminate how immune cells lock onto targets, the cellular recognition at the heart of autoimmune disorders and infections. Without a systematic way to look for these signals, many details of immune cells’ recognition capabilities have remained a mystery.

One type of immune cell, called a tumor-infiltrating lymphocyte, can invade tumors and help destroy cancer cells. Tumor-infiltrating lymphocytes have captured the attention of cancer researchers eager to supercharge these cells’ tumor-killing abilities. This destruction depends on lymphocytes correctly detecting cancer signals – bits of protein called antigens that cancer cells display on their surface. Lymphocytes use proteins called T-cell receptors to lock on to these cancer signals, many of which are unknown.

In 2014, Garcia and colleagues published an article in Cell reporting a discovery that T-cell receptors were far more specific for their targets than originally thought. They were able to make this discovery by developing a biochemical method to sift through millions of antigens that might be detected by T-cell receptors. In the new work, they apply a similar method to tumor samples from two colorectal cancer patients, this time searching for the actual targets of patients’ tumor-invading lymphocytes.

Along with graduate student Marvin Gee, Garcia enlisted the collaboration of Mark Davis, an HHMI investigator at Stanford University. Davis’s laboratory has developed ways to read the DNA sequences of single lymphocytes – information that helped researchers hunt for immune cells’ targets. First, Davis and post-doctoral fellow Arnold Han isolated and characterized T-cell receptors from two patients with colorectal cancer. Next, the researchers used those precise T-cell receptors as bait, a labor-intensive process that involves searching through hundreds of millions of signals that cancer cells might display. These signals, short strings of amino acids, represent molecular needles in an enormous haystack.

But the method worked. And the researchers discovered something surprising: Out of a huge number of possibilities, the T-cell receptors from both patients recognized the same tumor antigen. The results support the approach of developing broadly effective cancer treatments based on the immune system. “We have to find antigens that are shared across multiple different patients, so that one treatment can serve many different people,” Garcia says.

These shared signals could prove useful in several ways. In laboratories, researchers could genetically engineer T-cell receptors to recognize common cancer antigens. Once introduced into a patient’s body, these cells would make a beeline to the tumor cells. A related approach would turn the cancer antigen itself into a vaccine. After an injection, this cancer vaccine would teach existing immune cells to recognize and combat the rogue cells.

The new results have implications that reach far beyond cancer, too. The method could illuminate the cellular details of autoimmune disorders, infectious diseases or any other process that involves T-cell receptors, Garcia says.

The current findings were rooted in a result from 1996, when Garcia and colleagues first solved the 3-D structure of a T-cell receptor bound to a target. Since then, the work has moved steadily from basic research to clinically relevant insights, Garcia says. “This is a great example of how starting with the most reductionist approach can lead you to very powerful insights with clinical relevance,” he says. “If you invest in the most basic discovery science, and you go deep enough on an important problem, here’s what can come out the other end.”


Explore further:
Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

More information:
Cell (2017). DOI: 10.1016/j.cell.2017.11.043

Journal reference:
Cell

Provided by:
Howard Hughes Medical Institute

Tagged with:

About author

Related Articles